Suppr超能文献

子宫内膜异位症似乎不是体外受精/卵胞浆内单精子注射周期中妊娠高血压疾病的影响因素。

Endometriosis does not seem to be an influencing factor of hypertensive disorders of pregnancy in IVF / ICSI cycles.

机构信息

Reproductive Medicine Center, The First Affiliated Hospital of Sun Yat-sen University, Zhoushan 2 Road, Guangzhou, Guangdong, People's Republic of China.

Guangdong Provincial Key Laboratory of Reproductive Medicine, The First Affiliated Hospital of Sun Yat-sen University, Zhoushan 2 Road, Guangzhou, Guangdong, People's Republic of China.

出版信息

Reprod Biol Endocrinol. 2022 Mar 25;20(1):57. doi: 10.1186/s12958-022-00922-5.

Abstract

INTRODUCTION

To evaluate whether the incidence of hypertensive disorders of pregnancy (HDP) in pregnant women was related to endometriosis (EM), ovulation and embryo vitrification technology.

METHODS

A retrospective cohort study was conducted on the clinical data of 3674 women who were treated with IVF / ICSI in the Reproductive Medicine Center of the First Affiliated Hospital of Sun Yat-sen University and maintained clinical pregnancy for more than 20 weeks. All pregnancies were followed up until the end of pregnancy. The follow-up consisted of recording the course of pregnancy, pregnancy complications, and basic situation of newborns.

RESULTS

Compared with NC-FET without EM, HRT-FET without EM was found to have a higher incidence of HDP during pregnancy (2.7% V.S. 6.1%, P<0.001); however, no significant difference was found in the incidence of HDP between NC-FET and HRT-FET combined with EM (4.0% V.S. 5.7%, P>0.05). In total frozen-thawed embryo transfer (total-FET), the incidence of HDP in the HRT cycle without ovulation (HRT-FET) was observed to be higher than that in the NC cycle with ovulation (NC-FET) (2.8% V.S. 6.1%, P<0.001). In patients with EM, no significant difference was found in the incidence of HDP between fresh ET and NC-FET (1.2% V.S. 4.0%, P>0.05).

CONCLUSION

EM does not seem to have an effect on the occurrence of HDP in assisted reproductive technology. During the FET cycle, the formation of the corpus luteum may play a protective role in the occurrence and development of HDP. Potential damage to the embryo caused by cryopreservation seems to have no effect on the occurrence of HDP.

摘要

介绍

评估子宫内膜异位症(EM)、排卵和胚胎玻璃化技术是否与妊娠高血压疾病(HDP)的发生有关。

方法

对中山大学附属第一医院生殖医学中心接受体外受精/卵胞浆内单精子注射(IVF/ICSI)治疗并维持临床妊娠 20 周以上的 3674 名妇女的临床资料进行回顾性队列研究。所有妊娠均随访至妊娠结束。随访包括记录妊娠过程、妊娠并发症和新生儿基本情况。

结果

与无 EM 的 NC-FET 相比,无 EM 的 HRT-FET 妊娠期间 HDP 的发生率更高(2.7%比 6.1%,P<0.001);然而,EM 联合 NC-FET 和 HRT-FET 之间 HDP 的发生率无显著差异(4.0%比 5.7%,P>0.05)。在总冻融胚胎移植(total-FET)中,无排卵的 HRT 周期(HRT-FET)中 HDP 的发生率高于有排卵的 NC 周期(NC-FET)(2.8%比 6.1%,P<0.001)。在 EM 患者中,新鲜胚胎移植和 NC-FET 之间 HDP 的发生率无显著差异(1.2%比 4.0%,P>0.05)。

结论

EM 似乎不会影响辅助生殖技术中 HDP 的发生。在 FET 周期中,黄体的形成可能对 HDP 的发生和发展起到保护作用。胚胎冷冻保存对 HDP 的发生似乎没有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3e6/8957116/9d9e0c15426c/12958_2022_922_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验